ArticleExperimental and therapeutic medicine2021

Role of combining neutrophil-to-lymphocyte ratio and pretreatment body mass index in predicting progression-free survival in patients with non-small cell lung cancer treated with nivolumab.

Radu Dragomir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.